Two Sigma Investments
TXG icon

Two Sigma Investments’s 10x Genomics TXG Stock Holding History

Two Sigma Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,000
Closed -$1.04M – 4311
2021
Q4 		$1.04M Buy
+7,000
New +$1.07M ﹤0.01% 2531

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's TXG Position: Q1 2026 in Review

Two Sigma Investments reduced its 10x Genomics (TXG) stake by 65% in Q1 2026, selling an estimated $15.1M and leaving 402,427 shares worth $8.54M. The position accounts for 0.01% of the portfolio, ranked #1519.

Two Sigma Investments first reported a position in TXG in Q4 2020 and has held it in 19 quarters since. The position peaked at $18.9M in Q4 2024. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Two Sigma Investments held 402,427 shares of 10x Genomics worth $8.54M as of Q1 2026.
  • Two Sigma Investments sold 753,264 10x Genomics shares in Q1 2026, an estimated $15.1M.
  • 10x Genomics made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1519 holding.
  • Two Sigma Investments first reported a position in 10x Genomics in Q4 2020 and has held it in 19 quarters since.
  • Two Sigma Investments's 10x Genomics position peaked at $18.9M in Q4 2024.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.